0001209191-17-063316.txt : 20171201
0001209191-17-063316.hdr.sgml : 20171201
20171201185643
ACCESSION NUMBER: 0001209191-17-063316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171130
FILED AS OF DATE: 20171201
DATE AS OF CHANGE: 20171201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu David Y
CENTRAL INDEX KEY: 0001675881
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 171235233
MAIL ADDRESS:
STREET 1: C/O PROTAGONIST THERAPEUTICS, INC.
STREET 2: 521 COTTONWOOD DRIVE, SUITE 100
CITY: MILPITAS
STATE: CA
ZIP: 95035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980505495
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-30
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001675881
Liu David Y
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
0
1
0
0
Chief Scientific Officer
Common Stock
2017-11-30
4
A
0
875
1.89
A
4697
D
Common Stock
2017-11-30
4
S
0
875
20.00
D
3822
D
Employee Stock Option (right to buy)
1.89
2017-11-30
4
M
0
875
0.00
D
2024-10-22
Common Stock
875
12350
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017.
The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.
/s/ Thomas P. O'Neill, Attorney-in-Fact
2017-12-01